Autonomic system Flashcards
B adrenergic R in heart
B1 > B2 subtype
Types of B adrenergic R and effects
o B1-R subtype: concentration => SA node (7x) > ventricles > atrial + AV node
o B2 R subtype: non cardiac = bronchodilation
Inotropic + lusitropic effects from terminal neurons of cardiac ∑ nerves (NE release)
o B3 R subtype: adipose tissue > heart
Mediate breakdown of fat
Negative inotropic effect: might contribute to poor fct in CHF
Intracell signaling B-R
o Adrenergic stim → release Epi (adrenal gland) + NE (nerve terminal) → β-R
o G protein coupled R => bind to GTP prot => activate (Gs) adenylyl cyclase => incr cAMP → activate PKA => intra¢ signals
Effects of B stim on heart
+ inotrope
+ lusitrope
+ chronotrope
+ dromotrope
MOA + inotrope effect of B-R stim
incr rate of contraction + force developed
PKA → Pi L-type Ca2+ channels → incr Ca2+ entry through ¢ membrane => incr Ca2+ induced Ca2+ release from RyR=> incr intra¢ Ca2+
* incr Myosin ATPase activity => incr rate of development of contractile force
* incr Ca2+ interaction w TnC => incr force developed
* Calmodulin activation => incr PDE activity => incr cAMP breakdown
MOA + lusitrope effect of B-R stim
Phospholamban-Pi on SR + incr [Ca2+] => incr activity of Ca2+ pump
TnI-Pi by PKA => incr rate of crossbridge detachment
MOA + chornotrope effect of B-R stim
PM stimulation (SA node)
MOA + dromotrope effect of B-R stim
incr conduction velocity down AV node => short PR
* Slow Ca2+ channel stimulation
incr conduction velocity down His bundle, Purkinje fibers
Explain feedback mechanism after B-R stim
o Desensitization: physiological decr response w/i minutes
Uncoupling: Sustained stimulation => B agonist R kinase (B ARK) => Pi of COOH tail of R => uncouples from Gs prot and ↑ affinity for arrestin → configuration change
* B ARK expression/activity: major regulator of cardiac contractile function
o Long term B stimulation => incr mRNA expression for B ARK
o Long term B blockade => decr B ARK
Desensitization also accentuated by Pi of β-R by PKA
* Prevent adverse effects of intracell ↑cAMP
o Internalization: long term inhibitory mechanism: prolonged desensitization B R sequestration and internalization
Can participate in growth signaling => formation of complex
* B-R/arrestin/tyrosine kinase
* Arrestin change molecular conformation of R
Reversible: resensitization → phosphatase release P group => R can be linked to G prot again
o Digestion: via intracell proteolytic enzymes
Irreversible
Effects of dobutamine on B adrenergic response
B1 R agonist => drug tolerance by desensitization + R downregulation
Effect of B blockers on B adrenergic response
o B blockers (atenolol, propanolol) => may be beneficial for decr B ARK expression → improve β adrenergic signaling
Effect of A stim on CV syst
- Substantial vascular effects → vasoconstriction → ↑ PVR and BP
Intracell signaling of A-R stim
o Release of NE (vascular nerve terminal) => bind to A-R (G protein) => activate adenylyl cyclase => incr cAMP => PKC => IP3 + DAG => incr cytosolic Ca2+
IP3 = phosphatidyl inositol system
* Stimulates release of Ca2+ from SR
DAG = diacyglycerase
* Lipophilic => stays in ¢ membrane => activate PKC
* Sustained vasoconstriction
Cardiac effects of A-R stim
o Small positive inotrope via post synaptic A1-R =
> IP3 => icnr Ca2+
Not major impact in normal myocardium
May have an effect in CHF: downregulation of B adrenergic response
Types of A adrenergic R
o Post synaptic A1-R: inhibited by prazosin
o Presynaptic A2-R: inhibited by Yohimbine
o Other R coupled to phospholipase C: Ang II-R
Intracell signaling of muscarinic/cholinergic R
- Ach (NT) => G protein coupled R => bind to GTP prot => inhibit (Gi) adenylyl cyclase => decr cAMP
o cGMP = opposite effects vs cAMP
Parasymp R types in heart
M2 > M3 (NO linked R on endothelium)
Types of parasymp cholinergic R
Nicotinic R: autonomic ganglia
* Respond to nicotine
* Inhibited by ganglion blocking agents (hexamethonium)
Muscarinic: in tissues
* Inhibited by atropine
* M2: associated w vagal nerve activity negative inotrope
Cardiac effects of cholinergic stim
Bradycardia
neg inotrope
neg dromotrope
MOA negative chronotrope effect of Ach
G dependent K+ channel opening => inhibit rate of spontaneous depol => slow SA node
Negative Treppe effect mediated by NO => decr HR
Ach directly inhibits SA node
MOA negative inotrope effect of Ach
Ventricles < atrial response to muscarinic agonists despite similar R density
* Shorten atrial AP
NO => activate guanylyl cyclase => incr cGMP => negative inotrope
* Also inhibit cAMP production
MOA negative dromotrope effect of Ach
Gi → inhibit conduction through AV node
Role of NO in psymp effect on heart
- NO may contribute to icnr inhibitory cGMP + incr Ach release
How is NO released and effect
Release by endothelial ¢ from incr blood flow/shear stress => diffuse in vascular smooth muscle ¢ => stimulate cGMP => incr cytosolic Ca2+ => vasodilation
Role of insulin and IGF
- Regulates ¢ growth
- Act on tyrosine kinase => signaling system that activates nuclear transcription => promotes growth
Effects of incr cAMP
Organelles influences by cAMP
* Activation of PK => Pi of
o Sarcolemmal prot of Ca2+ channel
o Phospholamban on SR
o TnI => Pi of inhibitory subunit = decr sensitivity to Ca2+ + promotes crossbridge detachment => incr relaxation
* PK: 2 subunits => regulatory or catalytic
o PK activity ratio proportional to cAMP levels
o PKA : predominates in cardiac ¢
o PKC: in response to A adrenergic, ET-I, Ang II
Other agents that incr cAMP
Glucagon
T3
Adenosine
PGI
Dopamine
PDEi
Histamine
MOA glucagon effect ion heart
hypoglycemia => incr glucagon secretion from pancreas => incr cAMP in liver ¢ => incr glycogen breakdown
o incrHR + contractility
MOA thyroxine effect on heart
Bind to nuclear R => stimulate variety of RNA formation => activate adenylyl cyclase
MOA adenosine effect on heart
formed by breakdown of ATP => couples to Gi
o Open K+ channel (IK-Ach) => hyperpolarization => inhibit Ca2+ entry → decr HR
o ↓ contractility from ↓ Ca2+
o Regulate apoptosis and protect from reperfusion injury
MOA prostacyclin effect on heart
PG released by vascular endothelium => Gs => activate AC => incr cAMP
MOA dopamine effect on heart
catecholamine NT => stimulate pre/post dopamine R
o Low [dopamine] → peripheral DA1-R → vascular SM relaxation → vasodilation
o High [dopamine] → central DA-R → ↑ NE release in nerve ending → activate β1-R → incr contractility
o ↑↑↑ High [dopamine] → cross reaction w/ α1-R → vasoconstriction
MOA PDEi effect on heart
inhibit cAMP breakdown => incr contractility, rate of relaxation, HR
MOA histamine effect on heart
H2 => coupled to AC => incr cAMP